A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis

• Status: Completed
• Trial end date: 2020-07-29
• Target enrollment: 0
• Participant gender: All

Summary

A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of AGS Compared to AGU for Acute Bronchitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd

Criteria

Inclusion Criteria:

• Both gender, 19 years ≤ age ≤ 75 years

• BSS(Bronchitis Severity Score) ≥ 5point at Visit 2 (Randomized Visit)

• Patients without fever based on Visit 2(Randomized Visit)

• Those who can comply with the requirements of clinical trials

• Written consent voluntarily to participate in this clinical trial

Exclusion Criteria:

• Patients with respiratory and systemic infections requiring systemic antibiotic therapy

• Patients with bleeding tendency or coagulation disorder

• Patients who investigators determines to severe respiratory disease that would interfere with study assessment

• Those who have participated in other clinical trials within 4 weeks before participating in clinical trials

• In case the investigator judges that it is not suitable for the subject of this clinical trial for other reasons